Özet
CHA2DS2-VASc score includes similar risk factors for coronary artery disease. We hypothesized that admission CHA2DS2-VASc score might be predictive of adverse clinical outcomes for patients with ST-segment elevation myocardial infarction (STEMI) who were undergoing primary percutaneous coronary intervention. A total of 647 patients with STEMI enrolled in this study. The study population was divided into 2 groups according to their admission CHA2DS2-VASc score. The low group (n = 521) was defined as CHA2DS2-VASc score ≤2, and the high group (n = 126) was defined as CHA2DS2-VASc score >2. Patients in the high group had significantly higher incidence of in-hospital cardiovascular mortality (8.7% vs 1.9%; P <.001). Long-term mortality was significantly frequent in the high group (13.4% vs 3.6%, P <.001). Hypertension, admission CHA2DS2-VASc score, and Killip class >1 were independent predictors of long-term mortality. Admission CHA2DS2-VASc score >2 was identified as an effective cutoff point for long-term mortality (area under curve = 0.821; 95% confidence interval: 0.76-0.89; P <.001). CHA2DS2-VASc score is a simple, very useful, easily remembered bedside score for predicting in-hospital and long-term adverse clinical outcomes in STEMI.
Orijinal dil | İngilizce |
---|---|
Sayfa (başlangıç-bitiş) | 132-138 |
Sayfa sayısı | 7 |
Dergi | Clinical and Applied Thrombosis/Hemostasis |
Hacim | 23 |
Basın numarası | 2 |
DOI'lar | |
Yayın durumu | Yayınlanan - 1 Mar 2017 |
Harici olarak yayınlandı | Evet |